D.A. Davidson & Co. Bausch Health Companies Inc. Transaction History

D.A. Davidson & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$13.31 - $20.51 $352,182 - $542,694	-26,460 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$12.98 - $30.25 $28,556 - $66,550	-2,200 Reduced 7.68%	26,460 $410,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $32,113 - $54,213	-1,700 Reduced 5.6%	28,660 $858,000
Q3 2019 Nov 05, 2019	BUY	$20.88 - $25.66 $15,660 - $19,245	750 Added 2.53%	30,360 $663,000
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $55,404 - $71,415	2,700 Added 10.03%	29,610 $747,000
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $176,001 - $228,723	8,700 Added 47.78%	26,910 $665,000
Q4 2018 Jan 29, 2019	BUY	$17.64 - $28.32 $33,516 - $53,808	1,900 Added 11.65%	18,210 $336,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $336,638 - $418,677	16,310 New	16,310 $419,000

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.